Szczech L - Search Results

1

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group. Mocroft A, et al. Among authors: szczech l. AIDS. 2009 Jan 2;23(1):71-82. doi: 10.1097/QAD.0b013e32831cc129. AIDS. 2009. PMID: 19050388 Free PMC article. Clinical Trial.

2

Microalbuminuria in HIV infection.

Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG. Szczech LA, et al. AIDS. 2007 May 11;21(8):1003-9. doi: 10.1097/QAD.0b013e3280d3587f. AIDS. 2007. PMID: 17457094 Free PMC article.

3

Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG. Odden MC, et al. Arch Intern Med. 2007 Nov 12;167(20):2213-9. doi: 10.1001/archinte.167.20.2213. Arch Intern Med. 2007. PMID: 17998494 Free PMC article.

4

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM. Kalayjian RC, et al. AIDS. 2008 Feb 19;22(4):481-7. doi: 10.1097/QAD.0b013e3282f4706d. AIDS. 2008. PMID: 18301060 Free PMC article. Clinical Trial.

5

Acute kidney injury in HIV-infected patients.

Kalim S, Szczech LA, Wyatt CM. Kalim S, et al. Semin Nephrol. 2008 Nov;28(6):556-62. doi: 10.1016/j.semnephrol.2008.08.008. Semin Nephrol. 2008. PMID: 19013326 Free PMC article. Review.

6

Kidney disease in patients with HIV infection and AIDS.

Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Winston J, et al. Among authors: szczech l. Clin Infect Dis. 2008 Dec 1;47(11):1449-57. doi: 10.1086/593099. Clin Infect Dis. 2008. PMID: 18947327 Review.

7

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.

Choi A, Scherzer R, Bacchetti P, Tien PC, Saag MS, Gibert CL, Szczech LA, Grunfeld C, Shlipak MG. Choi A, et al. Among authors: szczech la. Am J Kidney Dis. 2010 Nov;56(5):872-82. doi: 10.1053/j.ajkd.2010.05.019. Epub 2010 Aug 14. Am J Kidney Dis. 2010. PMID: 20709438 Free PMC article.

8

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ. Estrella MM, et al. J Acquir Immune Defic Syndr. 2010 Oct;55(2):217-20. doi: 10.1097/QAI.0b013e3181e674f4. J Acquir Immune Defic Syndr. 2010. PMID: 20581688 Free PMC article.

9

Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease.

Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Schwartz EJ, et al. J Am Soc Nephrol. 2005 Aug;16(8):2412-20. doi: 10.1681/ASN.2005040340. Epub 2005 Jun 29. J Am Soc Nephrol. 2005. PMID: 15987747

10

National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients.

Owen WF Jr, Szczech L, Johnson C, Frankenfield D. Owen WF Jr, et al. Among authors: szczech l. Am J Kidney Dis. 1999 Oct;34(4 Suppl 2):S5-S11. doi: 10.1053/AJKD034s00005. Am J Kidney Dis. 1999. PMID: 10516369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page